UBI project awarded at Mötesplats Västerbotten: “Recognition for the work we have done”

Umeå Biotech Incubator (UBI) has won the Regio Stars Västerbotten 2023 award for its ‘Life Science Motorn 2.0’ regional fund project in the category “A region with localized sustainable business development”.
“It feels amazing that our project is being recognized and praised”, says UBI’s outgoing CEO, Jennie Ekbeck, who was the project manager behind the ‘Life Science Motorn 2.0’.

Read more

MedTech consultant company establishes in Umeå

Life science consulting company Orderly People has announced it will base one of its consultants in Umeå after the summer.
“There is a vibrant life science industry in Umeå which we want to be a part of”, says Orderly People’s founder and co-owner, Maria Jansson.

Read more

HiloProbe enters strategically important partnership with Biocartis

Umeå based HiloProbe AB has entered a partnership with the major international company Biocartis Group NV. This is a strategically important step for HiloProbe in their aim to reach out globally with its colorectal cancer test-product, ColoNode®.
“We are very happy to start a collaboration and a long-term relationship with Biocartis, which strengthens our focus on colorectal cancer thanks to Biocartis’ established sales and distribution network across many countries”, Lina Olsson, CEO of HiloProbe, says.

Read more

New international board promises to take Omnio to the next level

Umeå-based biopharmaceutical company Omnio AB, which is currently awaiting efficacy data from preclinical wound studies using recombinant plasminogen, has recently appointed an internationally experienced board of directors charged with taking the company forward.
“Our new board’s network and experience will allow us to build strategic partnerships with pharmaceutical and biotechnology companies, accelerate our clinical development program and ultimately bring our wound-healing candidate to market”, says Ulrika Norin, CEO of Omnio.

Read more

UBI hosts “Life science super week” with four events in three days

Umeå Biotech Incubator (UBI) is ending its development project program period with the “Life science super week” between May 8th-10th 2023 – an action-packed three-day event filled with seminars, an investment day, a life science pub plus a brand new services business fair.
“Life science in Umeå is buzzing right now, so pulling together several events at the same time gives us great synergistic effects”, says Jennie Ekbeck, UBI’s CEO.

Read more

Huge interest in emerging cancer treatment from G4 Cancer Cure

G4 Cancer Cure, a biotech research initiative located in Umeå in northern Sweden, has attracted considerable interest from doctors and the pharmaceutical industry for a new treatment method it is developing for triple-negative breast cancer.
Breast cancer is the most common cancer to affect women around the world, with approximately 15 percent of all cases diagnosed as triple-negative breast cancer. G4 Cancer Cure’s progress towards a treatment method is therefore being followed very closely, according to Project Manager Stefanie Sandberg.
“Our needs analysis shows there is huge interest in a new treatment method from doctors as well as pharmaceutical companies, experts and investors”, she says.

Read more

Kunskapsportalen för Life science-bolag vässas med nytt utbildningsmaterial

Sjösatt, uppskattad och under ständig utveckling. Kunskapsportalen vässas nu ytterligare med nytt utbildningsmaterial för flera efterfrågade områden.
– Vi ser att det är många olika forskare, entreprenörer och start-up företag som har hittat till plattformen. Vi hoppas att det nya innehållet ökar plattformens attraktionskraft ännu mer, säger Jennie Ekbeck, ordförande för Kunskapsportalens styrgrupp.

Read more

Two pre-incubator cases break new ground at Umeå Biotech Incubator

Umeå Biotech Incubator is expanding. Shades of Green and Cropcision are two new cases in the pre-incubator that work with a mix of biotech and architecture and in agtech with the next generation of sustained release systems.
”I applaud UBI to open the doors to entrepreneurs that want to develop ideas within plant biotech, agtech or food tech”, says Daniel Pacurar, who runs the case Shades of Green.

Read more

Argentinian startup praises the International Incubator Program at UBI

Brian Reznik from Argentina was one of the first participants of a new international incubator course hosted by Umeå Biotech Incubator (UBI) that is aimed at helping life science startups.
“We received a lot of help from UBI – among other things in regards to interviews and validation. They really helped us navigate our way through our challenges”, he says.

Read more

Neores joins UBI in push to go global with ground-breaking breathing aid for premature babies

In 2019 the research group behind R&D company Neores won both the Athena prize and the Medtech4Health Innovation Award for their rPAP breathing aid designed for babies born too early. Now Neores has announced it is taking the next step in building its business – where one goal is to reach the US market – by joining Umeå Biotech Incubator (UBI).
“Neores is an academic spinoff, so our ambition was never to make money or expand. But if we are to reach out more widely with our product we need to become more like a normal company”, says Thomas Drevhammar, CEO of the Östersund-based business.

Read more

Strong start to 2023 for InfiCure Bio

The life science company InfiCure Bio has started the new year in the best way by signing an agreement with a new client in the US.
“It’s all part of a positive trend that started in the autumn of 2022, and which is getting even stronger now that the US market is recovering after the pandemic. This latest agreement is proof of that”, says InfiCure Bio’s CEO, Sofia Mayans.

Read more

UBI hosts life science seminar at Grand Hôtel in Stockholm

Umeå Biotech Incubator (UBI) will represent Umeå’s life science industry as part of the annual ‘Västerbotten på Grand Hôtel i Stockholm’ event being held in January.
“We want to contribute to Umeå’s growth as a life science city by connecting the life science industry with local, regional, and national decision-makers”, says UBI’s CEO Jennie Ekbeck.

Read more

UmanDiagnostics expands to meet demand

UmanDiagnostics is experiencing growing pains and is expanding its current premises in Umeå.
“We have very efficient premises that we are extremely satisfied with, and this expansion will enable us to increase productivity and deliver more products to the market”, says Niklas Norgren, Vice President and Managing Director at UmanDiagnostics.

Read more

InfiCure Bio signs agreement with two major international companies

The Umeå based life science company InfiCure Bio continues to take large steps in the global market by signing agreements with two major international companies.
“The contracts with our new clients clearly show that pharmaceutical companies continue to invest in the development of new drugs for fibrosis, which is extremely promising for InfiCure Bio”, says InfiCure Bio’s CEO, Sofia Mayans.

Read more